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An increasing elderly population, a rising incidence of diﬀerentiated thyroid carcinoma (DTC), and a rising incidence of benign
nodular disease with age are all contributing to a rise in thyroid operations for the elderly. Literature review on the outcome and
safety of thyroid surgery in elderly patients has been filled with conflicting results and this subject remains controversial. Although
most single-institution studies conducted by high-volume surgeons did not find significant diﬀerences of complication rates in
elderly when compared with younger cohorts, they often lacked the power necessary to identify subtle diﬀerences and suﬀered
from various selection and referral biases. Recent evidence from large population-based studies concluded that thyroid surgery in
the elderly was associated with higher complication rates. One of the major contributing factors for the increased complication rate
was because most elderly patients suﬀered from many preexisting comorbidities. Therefore, elderly patients who have abnormal
thyroid findings should complete a thorough preoperative workup and better postoperative care after undergoing any thyroid
surgery. Furthermore, these high-risk patients would benefit if they could be referred to high-volume, specialized surgical units
early. In this systemic review, we aimed to evaluate diﬀerent issues and controversies in thyroidectomy for elderly patients.
1. Introduction
Both benign and malignant thyroid diseases occur com-
monly in the elderly population and this is partly related
to the fact that the incidence of thyroid nodules increase
with age [1]. It is clear that our general population is aging
rapidly and the proportion of the elderly has increased
by 90% over the last 30 years. It is projected that by
the year 2020, the proportion of patients aged ≥65 years
old would reach 20% from the 12.4% [2]. Since thyroid
surgery remains one of the most commonly performed
operations worldwide, thyroid surgery in the elderly has
become an important topic in endocrine surgery [3–6]. In
general, the common surgical indications such as thyroid
cancer, multinodular goiter (MNG), and hyperthyroidism
are similar between the young and elderly patients [7, 8].
However, since it is generally perceived that the elderly may
have increased operative risks because of the presence of
increasing number of comorbidities, a more conservative or
nonoperative approach is often adopted [3]. As a result, those
patients who really undergo thyroid surgery generally would
normally have a much “stronger” or more urgent indication,
such as those with more severe symptoms from their thyroid
disease (e.g., compressive symptoms) or those with suspected
or proven malignancy, than their younger counterparts.
However, these more urgent indications also generally pose
increased operative risk and so age per se may not account
for the increased operative risk [6, 7]. Furthermore, over
the last 10 years, major advances have occurred in gen-
eral and endocrine surgery, anesthesia, perioperative care,
instrumentation, and technology and they tend to reduce the
overall operative risk, allowing greater proportion of elderly
patients to undergo elective surgery [9]. To our knowledge,
information on the elderly population undergoing elective
thyroid operation remains scare. Furthermore, there is no
universally agreed definition on the term “elderly”. The cutoﬀ
age for “elderly” may vary from 60–80 years or older [3–
6, 10, 11]. The current literature on the outcome and safety
of thyroidectomy in elderly patients has been filled with
conflicting results and the topic remains controversial. Most
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single-institution studies concluded that thyroidectomy in
the elderly was not associated with increased complications
when compared with their younger counterparts [3, 5, 10,
12, 13]. However, several recent studies including two large
population-based series [4, 6] concluded that thyroidectomy
in the elderly were associated with higher risk for complica-
tions. In this review, we aimed to evaluate both safety and
surgical outcome on thyroid surgery in elderly patients. At
the same time, it would be important to examine the actual
cost and impact on quality of life in the elderly if elective
thyroid operation is decided.
2. Demographic and Clinical Characteristics
2.1. Age and Gender. As mentioned earlier, there has not
been any clear definition for the elderly or geriatric patient
in the medical literature. In the past, authors used diﬀerent
definitions or age groups to define elderly patients [3–
6, 10, 11]. Some studies defined any patients aged 65–79
years old as “elderly” and those aged 80 years and older as
“superelderly” [4, 14]. Bliss et al. defined patients 75 or older
as elderly [3] and some even described patients as young as
65 years as “elderly” [10]. Lang and Lo referred to patients
70 years or older as elderly in a retrospective analysis on
multinodular patients [5]. Mekel et al described patients 80
years or older as octogenarians or elderly group [15]. As a
result of this diﬀerence in definition, the actual proportion of
elderly patients undergoing elective thyroid surgery ranged
between 2.5% to 21.2%, depending on patient selection
and type of referral (Table 1) [3–6, 10, 15, 16]. In terms
of sex ratio, most reported series found that their cohort
was predominantly female with a female: male ratio of 4 : 1
[3, 4, 15]. This is mostly because thyroid diseases mostly
appear in the female sex and also because the females tend to
live longer and stay healthier for longer than the males and
so they are more likely to be fit for surgery.
2.2. Presentation and Surgical Indications. In the litera-
ture review, the main indications for surgery in elderly
patients were suspected or verified malignancy, mechanical
or compression symptoms, and followed by substernal or
retrosternal goiter (Table 1) [3, 5, 15, 16]. Bliss et al. reported
that the main indications for surgery in elderly were airway
compression and risk of malignancy [3]. Additionally, the
percentage of retrosternal goiter causing compression was
also significant higher in elder as compared to younger group
[3]. These results were consistent with Passler et al. who
demonstrated that suspected malignancy and mechanical
symptoms were significant higher in elderly patients whereas
benign goiters were the main indication for younger patients
[16]. Lang and Lo evaluated 279 patients undergoing total
thyroidectomy for MNG and reported that in addition to
retrosternal MNG, toxic MNG was also a common surgical
indication [5]. However, it should be pointed out that
the prevalence of retrosternal goiter would be significantly
higher if these series also included those who opted for
non-operative approach (i.e., observation or alternative
medicines). In our clinical practice, with increasing use of
axial imaging like CT or MRI, it is not uncommon for us to
receive referrals for managing elderly patients with incidental
finding of retrosternal goiter. Perhaps, a future study could
look at the natural course or history of elderly patients
with relatively asymptomatic retrosternal goiter and see
what proportion of patients without surgery would become
symptomatic and what proportion would benefit from early
surgery. In our experience, on average, we would see one
elderly patient per year requiring emergency admission
through the accident and emergency because of acute airway
obstruction from a large compressive goiter [17].
It is well known that thyroid cancer tends to behave
more aggressively and presents at a more advanced stage
in younger patients [3, 18, 19]. In fact, the current TNM
has used the age of 45 years old as the cutoﬀ between
good and bad risks. As a result, the incidence of local or
lymph node recurrence as well as proportion of secondary
thyroid surgery tends to be significant higher in elderly
group [3, 16]. Matsuyama et al. evaluated 85 patients with
thyroid cancers and demonstrated that successful surgery
for thyroid cancer increased the survival rate and improved
the quality of life of elderly patients [20]. Nevertheless, the
decision to perform surgery is not often straightforward
as reoperation for persistent or recurrent thyroid cancer is
generally associated with increased surgical morbidity and
reduced chance of actual cure when measured by stimulated
thyroglobulin level alone [21]. Mekel et al. evaluated 332
patients undergoing thyroid surgery and they failed to
demonstrate any significant diﬀerence between octogenarian
and younger patients in terms of preoperative indication
for surgery which included benign disease, suspected malig-
nancy, and suspected follicular neoplasm [15].
3. Surgical Procedure and Strategy
3.1. Comorbidity Indices. In general, patient comorbidity in
the literature was assessed either with Charlson comorbidity
index [22] or American Society of Anesthesiologists (ASA)
class [23]. The Charlson comorbidity index was originally
designed to classify prognostic comorbidity in longitudinal
study. It has been used in number of studies to stratify
patients adjusting for confounding influence of comorbid
conditions on outcome and overall survival. Charlson index
score was significantly higher in the octogenarians when
compared to the younger patients [15]. Sosa et al. demon-
strated that the superelderly (i.e., those aged ≥80 years old)
had significantly greater comorbidity burden with nearly
36% of patients having 3 or more comorbidities in addition
to their thyroid diagnosis [6]. The elderly patients also had
higher American Society of Anesthesiologists (ASA) class.
An ASA score >3 was found to be an independent risk
factor for nonsurgical-related complications after thyroid
surgeries but was not associated to increased incidence of
myocardial infarction or congestive cardiac failure [4]. The
ASA status of patients should be assessed preoperatively by
the anesthesiologist, as any evidence of increased risk should
result in an altered patient management scheme, including
pre-, intra-, and postoperatively. In other words, the ASA
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Table 1: A comparison of patient characteristics, definitions, indications, and procedures between diﬀerent elderly surgical series.
Study/year Design
Definition of “elderly”
(years)
Number of
patients (%)
Indications Types of procedure
Bliss et al.
[3]
(1999)
Retrospective
(1) Elderly ≥75
(2) 61–74
(3) 50–60
(1) 221 (13.5)
(2) 685 (42.1)
(3) 725 (44.4)
(i) Compression symptoms (i) Total thyroidectomy
(ii) Risk of malignancy (ii) Hemithyroidectomy
(iii) Hyperparathyroidism
(iii) Total Lobectomy & subtotal
thyroidectomy
(iv) Retrosternal goiter∗ (iv) Bilateral subtotal thyroidectomy
(v) Toxic symptoms (v) Enucleation of nodule
(vi) Completion (vi) Isthmectomy
(vii) Others (vii) Others
Passler et al.
[16]
(2002)
Retrospective (1) Geriatric ≥ 75
(2) Younger < 75
(1) 55 (7.5)
(2) 683 (92.5)
(i) Benign∗
(ii) Suspected malignancy
(iii) Malignancy
(iv) Mechanical symptoms
(i) Radical—total/near-total
thyroidectomy/hemithyroidectomy/neck
dissection
(ii) Nonradical—Enucleation/unilateral
subtotal/bilateral
thyroidectomy/hemithyroidectomy with
contralateral subtotal resection
Lang and
Lo [5]
(2005)
Retrospective (1) Elderly ≥ 70
(2) Young < 70
(1) 55 (18.5)
(2) 242 (81.5)
(i) Compression symptoms
(i) Total thyroidectomy
(ii) Near-total thyroidectomy
(ii) Thyrotoxicosis∗
(iii) Recent enlargement∗
(iv) Cosmesis/patient
request∗
(v) Suspicious FNAC
Sosa et al.
[6]
(2008)
Cross sectional
(population
based)
(1) Superelderly ≥ 80 (1) 744 (3.3)∗ NA (i) Subtotal/total thyroidectomy∗
(2) Elderly 65–79 (2) 4092 (17.9)∗ (ii) Substernal thyroidectomy∗
(3) 45–64 (3) 9959 (43.6)
(4) 18–44 (4) 8053 (35.2)
Mekel et al.
[15]
(2009)
Retrospective
(1) Octogenarian≥ 80
(2) 18–79
(i) Benign (i) Lobectomy/partial thyroidectomy
(1) 90 (2.5) (ii) Malignancy (ii) Total/subtotal thyroidectomy
(2) 250
(randomly
selected)
(iii) Microfollicular
(iv) Previous thyroid
surgery
Grogan et
al. [4]
(2012)
Prospective
cohort
(population
based)
(1) Superelderly ≥ 80 (1) 199 (2.51) NA (i) Total thyroidectomy
(2) Elderly 65–79 (2) 1322 (16.7) (ii) Lobectomy
(3) 16–64 (3) 6394 (80.8) (iii) Completion
(iv) With neck dissection
(v) Substernal goite cervical approach
(vi) Substernal goiter thoracic approach
Syebt et al.
[10]
(2012)
Prospective
non-
randomized
(1) Elderly > 65
(2) Young 21–35
(1) 44 (10.7)
(2) 86 (20)
(i) Benign
(ii) Malignancy
(i) Conventional thyroidectomy
(ii) Minimally invasive open
thyroidectomy
(iii) Endoscopic thyroidectomy
∗
Statistically significant (P < 0.01).
should in fact be part of the decision-making process in the
surgeon’s oﬃce before operative intervention.
3.2. Types of Procedures. Thyroid surgery remains the treat-
ment of choice for benign and malignant thyroid diseases.
Because of longer life expectancy and improved methods of
disease detection and treatment, there will be an increased
demand for thyroid surgical procedures in the elderly
patients population [24]. Bliss et al. reported a higher
incidence of secondary procedures on elderly patients and
significant diﬀerence between the proportion of total and
hemithyroidectomies (Table 1). The latter was significantly
more common in the younger group than in the elderly
groups [3]. Generally, older patients were less likely to
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undergo total thyroidectomy than younger patients as overall
patients had more preoperative comorbidities as reflected by
a higher ASA class [4, 6]. In addition, the older thyroidec-
tomy patients appear to have more advanced benign disease
as substernal thyroidectomies were required for elderly and
superelderly patients as compared to younger group [6].
Thyroid cancers behave generally more aggressive with
increasing age [18, 25]. Park et al. evaluated 8899 patients
who undergoing thyroidectomy and radioactive iodine (RAI)
from the Surveillance, Epidemiology, and End Results
(SEER) database in United States and found that older
patients aged ≥65 years were more likely to have multiple
primary tumours, advanced-staged disease, larger tumour,
extrathyroidal extension, and nonpapillary histology [26].
Despite their more aggressive disease, older patients were
less likely to undergo near-total/total thyroidectomy, lym-
phadenectomy, or to receive adjuvant radiation. These trends
were pronounced among those aged ≥80 years [26]. How-
ever, Matsuyama et al. compared patients with clinicopatho-
logical characteristics of Papillary thyroid carcinoma (PTC)
between the elderly and young groups and demonstrated
that there was no significant diﬀerence in the percentage
of patients with tumour size ≥4 cm, lymph node metastasis
≥3 cm, and distantmetastasis between these two groups [20].
Indications for near-total/total thyroidectomy and RAI in
patients with DTC have remained controversial. Because of
the generally good prognosis of DTC, prospective random-
ized trials of treatment with meaningful clinical endpoints,
such as tumor recurrence, distant metastasis, or cancer-
related death, have been diﬃcult if not impossible to
perform, because they would require a prohibitive number of
randomized patients and length of followup to achieve suf-
ficient power [27]. Overall, retrospective analyses indicated
that total thyroidectomy with RAI and suppressive hormone
therapy improved disease-free survival, reduced disease
recurrence, eradicated intrathyroid cancer, and facilitated the
use of whole-body iodine scans and thyroglobulin surveil-
lance monitoring for recurrence [28, 29]. Therefore, major
professional societies, such as the American Association
of Clinical Endocrinologists, the American Association of
Endocrine Surgeons, the National Comprehensive Cancer
Network, and the American Thyroid Association (ATA), have
recommended near-total or total thyroidectomy as the initial
procedure of choice for DTC and the addition of radioiodine
ablation for patients who have functioning remnants in the
thyroid bed or distant metastases [26, 30]. In addition, the
ATA also suggests that age >45 years also may be a criterion
for recommending near-total or total thyroidectomy because
of higher recurrence rates in this age group [30, 31].
4. Complications and Cost
Table 2 shows a summary of the actual monetary cost in
surgical series on thyroid surgery in the elderly. However,
the cost remains understudied. The risk of thyroidectomy
complications in elderly patients remains unclear. It has
been suggested that thyroid surgery in the elderly should
be restricted to those whose lesions are at higher risk of
malignancy, whereas others with little risk of malignancy
may be followed up [22]. However, since the standard of care
in thyroid surgery has improved, some of the elderly patients
are now referred to specialized endocrine surgical units as
these units tend to have better overall outcomes and lower
complications than less specialized centers [3]. Table 3 shows
a summary of the surgical series on thyroid surgery in the
elderly.
4.1. Surgical-Related Complications. Previous single-insti-
tution studies, which looked at complications in elderly
patients undergoing thyroid surgery, did not find significant
higher complication rates than younger patients [3, 5, 10,
13, 16]. Passler et al. [16] compared the outcomes of 55
patients aged ≥75 years with 683 younger patients and
found a rate of 25.5% early postoperative complications
in the elderly compared with 22% in the younger group
(Table 3). Early postoperative recurrent laryngeal nerve palsy
and postoperative hypocalcemia were the most frequent
complications in both age groups. In one study, early
postoperative recurrent laryngeal nerve palsy was found in
6 (6.3%) of 95 nerves at risk in elderly and 46 (3.9%) of 1172
nerves at risk in younger group. However, these diﬀerences
were not statistically significant and were consistent with
other centers [5, 10]. Although one study also suggested a
trend toward higher complications in the elderly, however
it was insignificant [16]. There were other studies reporting
surgically related complications such as hypoparathyroidism
and recurrent laryngeal nerve palsy but found no significant
diﬀerence between the elderly and young patients [3, 5, 10,
13]. In contrast, two recent large population-based studies
reported that thyroid surgery in the elderly was associated
with higher complication rates [4, 6]. Sosa et al. evaluated
the outcomes after thyroidectomy in patients 65 of age and
older in American and they demonstrated that endocrine-
specific complications for elderly and superelderly thyroid
surgery patients are considerably worse when compared to
the young patients [6].
4.2. Nonsurgical-Related Complications. Using the American
College of Surgeons National Surgical Quality Improvement
Program (ACS-NSQIP) data, Grogan et al. found that those
aged between 65–79 years old were twice (OD = 2.1,
95% CI: 1.4–3.3) as likely and those aged 80 years or
old five times (OD = 4.9, 95% CI: 2.5–9.6) as likely to
have a complication compared with younger counterparts
[12]. Furthermore, they found that advanced age was a
significant risk factor for pulmonary, cardiac, and infectious
complications [4]. In addition, they found that the high-
est rate of complications in the elderly and superelderly
groups was for the pulmonary origin. The common non-
surgically related complications included congestive cardiac
failure, atrial fibrillation, readmission for acute renal failure,
urosepsis, and transfusion requirement. Only a single center
study reported that the nonsurgically related complications
were significant higher in the elderly group (18.9%) as
compared to the younger group (5.2%) [15]. Lang and Lo
[5] evaluated total thyroidectomy in elderly patients and
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Table 2: A comparison of pathology, readmission rate, monetary cost, and hospital mortality in diﬀerent elderly patients’ series.
Study Design Pathology Readmission Cost
Mortality (within
30 days)
Bliss et al.
[3] (1999)
Retrospective
(i) MNG∗
(ii) Carcinoma∗
(iii) Adenoma∗ 0.87% (elderly)
(iv) Hashimato’s NA NA 0.1% (61–74)
(v) Single nodule 0.1% (50–60)
(vi) Graves
(vii) Others
Passler et al.
[16] (2002)
Retrospective
(i) PTC
(ii) FTC
(iii) ATC
(iv) MTC
NA NA 0%
(v) MTC + DTC
(vi) Others
Lang and Lo
[5] (2005)
Retrospective
(i) Functional (toxic)
MNG∗ NA NA 0%
(ii) Occult PTC
Sosa et al.
[6] (2008)
Cross sectional
(i) Benign∗ #(1) $ 7084 (6653-7514)∗ (1) 0.8%
(ii) Adenoma and cyst∗ NA #(2) $ 5917 (5769-6066)∗ (2) 0.2%
(iii) Malignancy∗ #(3) $ 5263 (5182-5344)∗ (3) 0.1%
#(4) $ 4905 (4821-4990)∗ (4) 0%
Mekel et al.
[15] (2009)
Retrospective
(i) Benign (1) 1.1% for
hypocalcaemia
(2) 0%
(ii) Malignancy NA
(iii) Incidental
micropapillary
0%
Grogan et al.
[4] (2012)
Prospective cohort NA NA NA 0%
Syebt et al.
[10] (2012)
Prospective
non-randomized
(i) Benign (1) 4.5%
NA
(ii) Malignancy (2) 1.2%
0%
∗
Statistically significant (P < 0.01).
#Adjusted for race, gender, hospital region, procedure, diagnosis, comorbidity, surgeon volume, household income, primary payer, and admission type in
superelderly, elderly, 45-64 and 18-44 cohorts.
PTC: Papillary thyroid cancer, FTC: Follicular thyroid cancer, MTC: Medullary thyroid cancer, DTC: Diﬀerentiated thyroid cancer.
also demonstrated a slightly higher incidence of overall non-
surgical related complications (5.5% versus 0.4%, P = 0.21)
such as pneumonia in the elderly group (4.3% versus 0.0%,
P = 0.003) (Table 3) [5]. Passler et al. also reported a higher
incidence of respiratory distress (3.6%) in elderly group but
it was no significant as compared to the younger group
(0.1%) [16]. Nevertheless, it is important to note that in
general thyroidectomy is a very safe operation with an overall
postoperative complications rate of around 1.3% [4].
4.3. Hospital Stay. Sosa et al. reported that average length of
stay (LOS) or hospital stay for patients aged 80 years and
older was 60% longer than for similar patients aged 65 to
79 years [6]. This finding was especially common in patients
80 years and older who had substantial comorbidities.
Lang and Lo evaluated 279 patients who underwent total
thyroidectomy forMNG showed that the overall hospital stay
for elderly patients (6.4 ± 7.2 days versus 3.7 ± 2.4 days,
P < 0.001) was statistically and significantly longer [5]. These
findings were consistent with a study of 3568 patients under-
going thyroid surgery at a single institution demonstrated
that the length of stay for octogenarians was significantly
longer than the younger counterpart [15]. Grogan et al. had
found that elderly (1.4 days) and superelderly (1.8 days)
had significant increases in the hospital stay compared with
the young (1.1 days) [4]. Therefore, there appeared to be a
linear relationship between the age of patients and the length
of hospital stay after surgery. However, similar relationships
between age and hospital stay were also observed in other
types of surgery such as cardiac or oncology [32]. These
findings remained significant even after controlling for a
number of clinical and demographic confounding factors.
4.4. Mortality. Direct comparison with other studies exam-
ining the rates of mortality in elderly patients is diﬃcult since
population groups and types of procedures diﬀer. The data
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Table 3: A comparison of complications between diﬀerent elderly surgical series.
Study/age group
Surgically related complications Non-surgically
related
complications
Temporary VC
palsy
Permanent
VC palsy
Temporary
hypocalcemia
Permanent
hypocalcemia
Hematoma
Wound
infection
Bliss et al. [3]
50–60 NA 1.4% 5% 0.2% 0.9%# 0.6%
61–74 1.6% 5.2% 0.1% 1.2%# 0.4% NA
Elderly 1.8% 3.9% 0.4% 0.9%# 0.4%
Passler et al. [16]
Geriatric 3.6% 1.05% 13.6% 2.3% 5.5% 1.8% 3.6%∧∧
Young 3.3% 0.26% 14.1% 5.4% 3.5% 0.4% 0.6%∧∧
Lang and Lo [5]
Elderly 3.6% 0.9% 14.5% 1.8% 1.8% 0% 5.5%∧
Young 3.3% 0.6% 19% 1.2% 0.8% 0% 0.4%∧
Sosa et al. [6]
Superelderly 3.6%∗ 6.6%∗
Elderly 2.4%∗ 4.3%∗
45–64 1.2%∗ 2.2%∗
18–44 1.1%∗ 1.5%∗
Mekel et al. [15]
Elderly 5.5%∗ 18.9%∗
18–79 2.5%∗ 5.2%∗
Grogan et al. [4] (Overall complications)
Superelderly 5%∗
Elderly 2.2%∗
16–64 1%∗
Syebt et al. [10]
Elderly 2.9% 0% 6.8% 0%
Young 3.9% 0% 5.8% 0%
NA NA NA
∗
Statistically significant (P < 0.01).
VC: vocal cord.
# Included haematoma with evacuation.
∧Included pneumonia, cardiac complications, and perforated peptic ulcer.
∧∧Included respiratory distress, pneumonia, and paralysis of brachial plexus.
on thyroid surgery in elderly patients for mortality remains
very limited (Table 2). In term of mortality, thyroidectomy
is safe in elderly patients in experienced hands [3]. In studies
with similar age spread, the 30-days mortality rates following
thyroid surgery are between 0 to 0.8% [3–6, 10, 13, 15, 16].
Two deaths were recorded in the elderly group (0.87%), both
due to advanced ATC and one death in the 50–60 years
group (0.1%) caused by ischemic heart disease [3]. Since
the mortality occurs rarely in thyroid surgery, both surgical-
and non-surgical-related complications appear to be good
end points for measuring the success of thyroid surgery
in the elderly. Nevertheless, larger, prospective studies that
include overall outcomes, long-term survival with mortality
and quality of life for elderly patients with operative thyroid
disease, are required.
4.5. Cost. Thyroid cancer increases in incidence and aggres-
siveness with age [33]. The elderly are the fastest growing
segment of USA population. Reducing rates of rehospital-
ization would lower cost and improve quality of care [34].
Recently, rehospitalization rates have gained prominence in
light of discourse about healthcare reform. There also have
been numerous reports in the popular press suggesting that
hospital readmission rates should be used as a measure
of quality of care and be tied to physician and hospital
reimbursement [35, 36]. Rohr showed that nearly one in five
Medicare beneficiaries are hospitalized within 30 days of a
hospital discharge, at a cost of $17.4 billion per year [37].
A large population-based study reported that patients 65
years and older had substantially longer hospitalizations than
younger patients, and their in-hospital care was associated
with substantially higher mean total costs [6]. For example,
average LOS for thyroidectomy in a superelderly patient
was more than a day longer than an elderly patient and
more than twice that for a patient 18 to 44 years (3.7
days versus 1.7 days, resp.; P < 0.001). Average cost of
thyroidectomy in a patient 80 years and older was $8,429,
39% more than the cost of the procedure in a patient 65
to 79 years, 55% more than a patient 45 to 64 years, and
59% more than a patient 18 to 44 years (P < 0.001).
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To our knowledge, the literature on rehospitalization and
cost after thyroidectomy on elderly is very limited. Only
one population-based study [10] and one SEER-database-
based study [34] describe patterns of rehospitalization after
thyroidectomy in elderly patients. Tuggle at al demonstrated
that 4% readmission rate was caused by endocrine-related
complications and another 4% were for the nonendocrine
complications [34]. Seybt et al. also reported that higher rate
of readmission in the elderly group (4.5%) as compared to
the young patients (1.2%). However, this finding was not
significant and none of the readmissions were attributable
to a cause related to age as all were caused by hypocalcemia
[10]. Furthermore, thyroidectomy has been shown to be safer
in high-volume surgeon centers than in low-volume surgeon
(one to thirty thyroidectomies per year) centers [14, 38].
Sosa et al. [14] reported the highest-volume surgeon had the
lowest complication rate (2.4%; P < 0.01), adjusted length of
stay (1.1 days; P < 0.001), and hospital charges ($2990 versus
$3620 to $4420; P < 0.001) compared to all surgeon volume
groups. However, the lowest-volume surgeons did the largest
share of the thyroidectomies for all age groups. When
combined with the fact that 50–80% of thyroid operations in
the United States are done in low-volume centers, the results
of these single-institution experiences are not generalizable
to the typical thyroidectomy patient [39].
5. Quality of Life (QOL)
To our knowledge, literature that addresses QOL in patients
with thyroid disease is very limited particularly for elderly
patients. The lack of literature is surprising given that thyroid
disease has been shown to have a significant impact on QOL
[40]. Matsuyama et al. evaluated 85 patients with thyroid
cancers and concluded that surgery for thyroid cancer
increased the survival rate and promoted the quality of life
of elderly patients if they could tolerate the procedure [20].
Others found that pneumonia and urinary tract infection
had significant adverse eﬀects on the QOL in elderly patients
after thyroidectomy [41, 42]. A retrospective survey of 7000
cancer patients at M. D. Anderson Cancer Center, 518 of
whom were thyroid cancer survivors, found that two-thirds
(64.5%) of the thyroid cancer patients reported that their
illness had significantly impacted their quality of life [43].
Surprisingly, when all other cancer survivors were asked
the same question, only 32.1% reported that their illness
had a significant impact. Shah et al. prospectively evaluated
seventy-six patients with DTC and reported that patients
with cancer experienced a greater drop in QOL during
the first 6 months following surgery when compared with
patients with benign disease (P < 0.03). However, patients
treated with total thyroidectomy did not have a significantly
diﬀerent QOL than patients treated with hemithyroidectomy
(P > 0.2) and they concluded that QOL should not be
a factor in the decision-making process for the treatment
of low-risk DTC [40]. A recent study from Germany also
reported that thyroid surgery could be performed safely and
without impairment of QOL, regardless of the extent of the
surgery in patients with benign goiter [44].
6. Conclusion
Even with all the knowledge acquired today, the safety of
thyroid surgery in elderly patients remains controversial.
Although retrosternal goiter is a common surgical indication
in the elderly and its prevalence might be more common
than previously believed, the natural history of the disease
in the elderly remains unknown and so it is diﬃcult for
surgeons to advise on elderly patients whether surgery is
really beneficial in the long term. In well-selected patient
cohort done by high-volume and experienced surgeons, no
significant increase in surgical morbidity andmortality could
be demonstrated. When dealing with elderly patients with
surgical thyroid disease, careful patient selection and making
referral to specialized high-volume center are necessary.
Elderly patients with concomitant medical problems require
to complete a thorough preoperative workup and assessment
before undergoing any thyroid surgery. Any pulmonary,
cardiac, or renal comorbidities should be optimized preop-
eratively. More data are needed in the future for analyses
concerning indications for thyroid operations in aging popu-
lation and the overall benefits, including long-term survival,
quality of life, recurrence, and the eﬀects of subsequent
need for additional treatment of their thyroid disease. Larger
prospective, population-based studies will probably provide
better understanding and optimal approach to the elderly
population in thyroid surgery.
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